Bookbuilding IPO | ₹74 Cr | Listed at BSE, NSE | Fri, Dec 17, 2004 - Thu, Dec 23, 2004
Indoco Remedies IPO is a book build issue of ₹73.50 crores. The issue is entirely a fresh issue of 0.30 crore shares of ₹73.50 crore.
Indoco Remedies IPO bidding started from Dec 17, 2004 and ended on Dec 23, 2004. The shares got listed on NSE and BSE on Jan 14, 2005.
Indoco Remedies IPO is set final issue price at ₹245 per share.
Axis Capital Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Indoco Remedies IPO RHP for detailed Information.
IPO Open
Fri, Dec 17, 2004
IPO Close
Thu, Dec 23, 2004
Issue Price
₹245 per share
Market Cap (Pre-IPO)
₹289.59 Cr
| IPO Date | 17 to 23 Dec, 2004 |
| Listed on | Fri, Jan 14, 2005 |
| Face Value | ₹10 per share |
| Price Band | ₹220 to ₹245 |
| Issue Price | ₹245 per share |
| Lot Size | |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 30,00,000 shares (agg. up to ₹74 Cr) |
| Fresh Issue | 30,00,000 shares (agg. up to ₹74 Cr) |
| Share Holding Pre Issue | 88,20,000 shares |
| Share Holding Post Issue | 1,18,20,000 shares |
| BSE Script Code / NSE Symbol | 532612 / INDOCO |
| ISIN | INE873D01024 |
INDOCO REMEDIES IPO comprises a total issue size of 30,00,000 shares. Out of which, 15,00,000 (50.00%) are allocated to QIB, 7,50,000 (25.00%) allocated to NII 7,50,000 (25.00%) allocated to RII.
| Investor Category | Shares Offered | % of Total Issue |
|---|---|---|
| QIB Shares Offered | 15,00,000 | 50.00% |
| NII (HNI) Shares Offered | 7,50,000 | 25.00% |
| Retail Shares Offered | 7,50,000 | 25.00% |
| Total Shares Offered | 30,00,000 | 100.00% |
Indoco Remedies Ltd. is a Mumbai-based, fully integrated pharmaceutical company that manufactures and markets finished dosage formulations and Active Pharmaceutical Ingredients (APIs) globally. The company operates 9 manufacturing facilities and exports to over 55 countries.
Indoco specialises in a broad range of therapeutic categories, including gastroenterology, dentistry, respiratory, diabetology, and women's health.
The company's key products include Cyclopam (antispasmodic), Febrex Plus (cough-and-cold syrup), Cital (urinary alkalizer), and Dentogel.
Indoco maintains international accreditations, including US FDA and UK MHRA, and holds an 85% stake in Florida Pharmaceutical Products (FPP) in the USA.
Indoco divested its ophthalmic business operations in identified emerging markets to Sunways in a strategic slump sale, allowing the company to refocus its core therapeutic operations.
The company generates over 109 million prescriptions annually from over 249,000 doctors nationwide.
| Period Ended | 31 Mar 2004 | 31 Mar 2003 | 31 Mar 2002 |
|---|---|---|---|
| Assets | 149.66 | 127.01 | 118.71 |
| Total Income | 177.61 | 146.53 | 132.12 |
| Profit After Tax | 21.26 | 14.67 | 16.55 |
| EBITDA | 3.56 | 2.45 | 2.28 |
| NET Worth | 87.64 | 71.12 | 71.45 |
| Reserves and Surplus | 79.19 | 62.91 | 62.94 |
| Amount in ₹ Crore | |||
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Dishman Pharmaceuticals & Chemicals Ltd. | Mainboard | ₹60.09 Cr | ₹175 | 12.64 | ₹541.25 | +209.29% | (+0.00%) |
| Biocon Ltd. | Mainboard | ₹315.00 Cr | ₹315 | 80.29 | ₹484.05 | +53.67% | ₹440.70 (+1.39%) |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Investment in subsidiary company, Indoco Healthcare Limited (IHL) for setting up of its plant to manufacture ointments, toothpaste, tablet, cephalosporin and meet UK MHRA, WHO and South Africa MCC standards | 25.79 |
| 2 | Setting up of plant to manufacture APIs | 22.00 |
| 3 | Setting-up of research and development Centre for APIs | 15.86 |
| 4 | Repayment of unsecured loan taken for acquisition of brand | 9.37 |
| 5 | Repayment of loan taken for acquisition of Office Premises | 5.21 |
| 6 | Issue expense | 5.00 |
| Total | 83.23 |
| KPI | Mar 31, 2004 |
|---|---|
| RoNW | 24.26%% |
| Price to Book Value | 2.47 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 24.10 | 17.99 |
| P/E (x) | 10.16 | 13.62 |
| Promoter Holding | 79.75% | 59.51% |
| Market Cap | ₹289.59 Cr. |
The Indoco Remedies IPO IPO subscription status. Full data available on IPOMatrix.com.
| Category | Subscription (times) | Shares Offered | Shares bid for | |
|---|---|---|---|---|
| Total | 60.74 | 30,00,000 | 18,22,10,075 | |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Management Fees, Underwriting Commission and Brokerage | 2.90 |
| 2 | Marketing and Advertising Expenses, Stationery and Printing, others (Registrar expenses, legal fees, listing fees etc.) | 2.10 |
| Total | 5.00 |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
Lead Manager Reports
Indoco Remedies IPO is a main-board IPO of 30,00,000 equity shares of the face value of ₹10 aggregating up to ₹74 Crores. The issue is priced at ₹245 per share. The minimum order quantity is .
The IPO opens on Fri, Dec 17, 2004, and closes on Thu, Dec 23, 2004.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Indoco Remedies IPO using UPI as a payment gateway. Zerodha customers can apply in Indoco Remedies IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Indoco Remedies IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Indoco Remedies IPO opens on Fri, Dec 17, 2004 and closes on Thu, Dec 23, 2004.
Indoco Remedies IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in Indoco Remedies IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Indoco Remedies IPO will be done on Wednesday, January 5, 2005, and the allotted shares will be credited to your demat account by . Check the Indoco Remedies IPO allotment status.
The Indoco Remedies IPO listing date is on Fri, Jan 14, 2005.
